Request for Covid-19 Impact Assessment of this Report
The United States Felodipine Sustained-Release Tablet market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Felodipine Sustained-Release Tablet market, reaching US$ million by the year 2028. As for the Europe Felodipine Sustained-Release Tablet landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Felodipine Sustained-Release Tablet players cover Astrazeneca, NanJing Easeheal Phaemaecutical, SHANXI KANGBO BIOLOGICAL PRODUCT, and Lifeon, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Felodipine Sustained-Release Tablet market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
2.5mg Per Tablet
5mg Per Tablet
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Treat High Blood Pressure
Relieve Angina
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Astrazeneca
NanJing Easeheal Phaemaecutical
SHANXI KANGBO BIOLOGICAL PRODUCT
Lifeon
Changzhou Siyao Pharmaceutical
Mylan
Sandoz
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Felodipine Sustained-Release Tablet Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Felodipine Sustained-Release Tablet by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Felodipine Sustained-Release Tablet by Country/Region, 2017, 2022 & 2028
2.2 Felodipine Sustained-Release Tablet Segment by Type
2.2.1 2.5mg Per Tablet
2.2.2 5mg Per Tablet
2.2.3 Others
2.3 Felodipine Sustained-Release Tablet Sales by Type
2.3.1 Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2022)
2.3.2 Global Felodipine Sustained-Release Tablet Revenue and Market Share by Type (2017-2022)
2.3.3 Global Felodipine Sustained-Release Tablet Sale Price by Type (2017-2022)
2.4 Felodipine Sustained-Release Tablet Segment by Application
2.4.1 Treat High Blood Pressure
2.4.2 Relieve Angina
2.4.3 Others
2.5 Felodipine Sustained-Release Tablet Sales by Application
2.5.1 Global Felodipine Sustained-Release Tablet Sale Market Share by Application (2017-2022)
2.5.2 Global Felodipine Sustained-Release Tablet Revenue and Market Share by Application (2017-2022)
2.5.3 Global Felodipine Sustained-Release Tablet Sale Price by Application (2017-2022)
3 Global Felodipine Sustained-Release Tablet by Company
3.1 Global Felodipine Sustained-Release Tablet Breakdown Data by Company
3.1.1 Global Felodipine Sustained-Release Tablet Annual Sales by Company (2020-2022)
3.1.2 Global Felodipine Sustained-Release Tablet Sales Market Share by Company (2020-2022)
3.2 Global Felodipine Sustained-Release Tablet Annual Revenue by Company (2020-2022)
3.2.1 Global Felodipine Sustained-Release Tablet Revenue by Company (2020-2022)
3.2.2 Global Felodipine Sustained-Release Tablet Revenue Market Share by Company (2020-2022)
3.3 Global Felodipine Sustained-Release Tablet Sale Price by Company
3.4 Key Manufacturers Felodipine Sustained-Release Tablet Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Felodipine Sustained-Release Tablet Product Location Distribution
3.4.2 Players Felodipine Sustained-Release Tablet Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Felodipine Sustained-Release Tablet by Geographic Region
4.1 World Historic Felodipine Sustained-Release Tablet Market Size by Geographic Region (2017-2022)
4.1.1 Global Felodipine Sustained-Release Tablet Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Felodipine Sustained-Release Tablet Annual Revenue by Geographic Region
4.2 World Historic Felodipine Sustained-Release Tablet Market Size by Country/Region (2017-2022)
4.2.1 Global Felodipine Sustained-Release Tablet Annual Sales by Country/Region (2017-2022)
4.2.2 Global Felodipine Sustained-Release Tablet Annual Revenue by Country/Region
4.3 Americas Felodipine Sustained-Release Tablet Sales Growth
4.4 APAC Felodipine Sustained-Release Tablet Sales Growth
4.5 Europe Felodipine Sustained-Release Tablet Sales Growth
4.6 Middle East & Africa Felodipine Sustained-Release Tablet Sales Growth
5 Americas
5.1 Americas Felodipine Sustained-Release Tablet Sales by Country
5.1.1 Americas Felodipine Sustained-Release Tablet Sales by Country (2017-2022)
5.1.2 Americas Felodipine Sustained-Release Tablet Revenue by Country (2017-2022)
5.2 Americas Felodipine Sustained-Release Tablet Sales by Type
5.3 Americas Felodipine Sustained-Release Tablet Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Felodipine Sustained-Release Tablet Sales by Region
6.1.1 APAC Felodipine Sustained-Release Tablet Sales by Region (2017-2022)
6.1.2 APAC Felodipine Sustained-Release Tablet Revenue by Region (2017-2022)
6.2 APAC Felodipine Sustained-Release Tablet Sales by Type
6.3 APAC Felodipine Sustained-Release Tablet Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Felodipine Sustained-Release Tablet by Country
7.1.1 Europe Felodipine Sustained-Release Tablet Sales by Country (2017-2022)
7.1.2 Europe Felodipine Sustained-Release Tablet Revenue by Country (2017-2022)
7.2 Europe Felodipine Sustained-Release Tablet Sales by Type
7.3 Europe Felodipine Sustained-Release Tablet Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Felodipine Sustained-Release Tablet by Country
8.1.1 Middle East & Africa Felodipine Sustained-Release Tablet Sales by Country (2017-2022)
8.1.2 Middle East & Africa Felodipine Sustained-Release Tablet Revenue by Country (2017-2022)
8.2 Middle East & Africa Felodipine Sustained-Release Tablet Sales by Type
8.3 Middle East & Africa Felodipine Sustained-Release Tablet Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Felodipine Sustained-Release Tablet
10.3 Manufacturing Process Analysis of Felodipine Sustained-Release Tablet
10.4 Industry Chain Structure of Felodipine Sustained-Release Tablet
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Felodipine Sustained-Release Tablet Distributors
11.3 Felodipine Sustained-Release Tablet Customer
12 World Forecast Review for Felodipine Sustained-Release Tablet by Geographic Region
12.1 Global Felodipine Sustained-Release Tablet Market Size Forecast by Region
12.1.1 Global Felodipine Sustained-Release Tablet Forecast by Region (2023-2028)
12.1.2 Global Felodipine Sustained-Release Tablet Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Felodipine Sustained-Release Tablet Forecast by Type
12.7 Global Felodipine Sustained-Release Tablet Forecast by Application
13 Key Players Analysis
13.1 Astrazeneca
13.1.1 Astrazeneca Company Information
13.1.2 Astrazeneca Felodipine Sustained-Release Tablet Product Offered
13.1.3 Astrazeneca Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Astrazeneca Main Business Overview
13.1.5 Astrazeneca Latest Developments
13.2 NanJing Easeheal Phaemaecutical
13.2.1 NanJing Easeheal Phaemaecutical Company Information
13.2.2 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product Offered
13.2.3 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 NanJing Easeheal Phaemaecutical Main Business Overview
13.2.5 NanJing Easeheal Phaemaecutical Latest Developments
13.3 SHANXI KANGBO BIOLOGICAL PRODUCT
13.3.1 SHANXI KANGBO BIOLOGICAL PRODUCT Company Information
13.3.2 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product Offered
13.3.3 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 SHANXI KANGBO BIOLOGICAL PRODUCT Main Business Overview
13.3.5 SHANXI KANGBO BIOLOGICAL PRODUCT Latest Developments
13.4 Lifeon
13.4.1 Lifeon Company Information
13.4.2 Lifeon Felodipine Sustained-Release Tablet Product Offered
13.4.3 Lifeon Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Lifeon Main Business Overview
13.4.5 Lifeon Latest Developments
13.5 Changzhou Siyao Pharmaceutical
13.5.1 Changzhou Siyao Pharmaceutical Company Information
13.5.2 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product Offered
13.5.3 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Changzhou Siyao Pharmaceutical Main Business Overview
13.5.5 Changzhou Siyao Pharmaceutical Latest Developments
13.6 Mylan
13.6.1 Mylan Company Information
13.6.2 Mylan Felodipine Sustained-Release Tablet Product Offered
13.6.3 Mylan Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Mylan Main Business Overview
13.6.5 Mylan Latest Developments
13.7 Sandoz
13.7.1 Sandoz Company Information
13.7.2 Sandoz Felodipine Sustained-Release Tablet Product Offered
13.7.3 Sandoz Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Sandoz Main Business Overview
13.7.5 Sandoz Latest Developments
14 Research Findings and Conclusion
Table 1. Felodipine Sustained-Release Tablet Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Felodipine Sustained-Release Tablet Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 2.5mg Per Tablet
Table 4. Major Players of 5mg Per Tablet
Table 5. Major Players of Others
Table 6. Global Felodipine Sustained-Release Tablet Sales by Type (2017-2022) & (K Units)
Table 7. Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2022)
Table 8. Global Felodipine Sustained-Release Tablet Revenue by Type (2017-2022) & ($ million)
Table 9. Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2017-2022)
Table 10. Global Felodipine Sustained-Release Tablet Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Felodipine Sustained-Release Tablet Sales by Application (2017-2022) & (K Units)
Table 12. Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2022)
Table 13. Global Felodipine Sustained-Release Tablet Revenue by Application (2017-2022)
Table 14. Global Felodipine Sustained-Release Tablet Revenue Market Share by Application (2017-2022)
Table 15. Global Felodipine Sustained-Release Tablet Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Felodipine Sustained-Release Tablet Sales by Company (2020-2022) & (K Units)
Table 17. Global Felodipine Sustained-Release Tablet Sales Market Share by Company (2020-2022)
Table 18. Global Felodipine Sustained-Release Tablet Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Felodipine Sustained-Release Tablet Revenue Market Share by Company (2020-2022)
Table 20. Global Felodipine Sustained-Release Tablet Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Felodipine Sustained-Release Tablet Producing Area Distribution and Sales Area
Table 22. Players Felodipine Sustained-Release Tablet Products Offered
Table 23. Felodipine Sustained-Release Tablet Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Felodipine Sustained-Release Tablet Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Felodipine Sustained-Release Tablet Sales Market Share Geographic Region (2017-2022)
Table 28. Global Felodipine Sustained-Release Tablet Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Felodipine Sustained-Release Tablet Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Felodipine Sustained-Release Tablet Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Felodipine Sustained-Release Tablet Sales Market Share by Country/Region (2017-2022)
Table 32. Global Felodipine Sustained-Release Tablet Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Felodipine Sustained-Release Tablet Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Felodipine Sustained-Release Tablet Sales by Country (2017-2022) & (K Units)
Table 35. Americas Felodipine Sustained-Release Tablet Sales Market Share by Country (2017-2022)
Table 36. Americas Felodipine Sustained-Release Tablet Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Felodipine Sustained-Release Tablet Revenue Market Share by Country (2017-2022)
Table 38. Americas Felodipine Sustained-Release Tablet Sales by Type (2017-2022) & (K Units)
Table 39. Americas Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2022)
Table 40. Americas Felodipine Sustained-Release Tablet Sales by Application (2017-2022) & (K Units)
Table 41. Americas Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2022)
Table 42. APAC Felodipine Sustained-Release Tablet Sales by Region (2017-2022) & (K Units)
Table 43. APAC Felodipine Sustained-Release Tablet Sales Market Share by Region (2017-2022)
Table 44. APAC Felodipine Sustained-Release Tablet Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Felodipine Sustained-Release Tablet Revenue Market Share by Region (2017-2022)
Table 46. APAC Felodipine Sustained-Release Tablet Sales by Type (2017-2022) & (K Units)
Table 47. APAC Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2022)
Table 48. APAC Felodipine Sustained-Release Tablet Sales by Application (2017-2022) & (K Units)
Table 49. APAC Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2022)
Table 50. Europe Felodipine Sustained-Release Tablet Sales by Country (2017-2022) & (K Units)
Table 51. Europe Felodipine Sustained-Release Tablet Sales Market Share by Country (2017-2022)
Table 52. Europe Felodipine Sustained-Release Tablet Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Felodipine Sustained-Release Tablet Revenue Market Share by Country (2017-2022)
Table 54. Europe Felodipine Sustained-Release Tablet Sales by Type (2017-2022) & (K Units)
Table 55. Europe Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2022)
Table 56. Europe Felodipine Sustained-Release Tablet Sales by Application (2017-2022) & (K Units)
Table 57. Europe Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Felodipine Sustained-Release Tablet Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Felodipine Sustained-Release Tablet Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Felodipine Sustained-Release Tablet Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Felodipine Sustained-Release Tablet Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Felodipine Sustained-Release Tablet Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Felodipine Sustained-Release Tablet Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Felodipine Sustained-Release Tablet
Table 67. Key Market Challenges & Risks of Felodipine Sustained-Release Tablet
Table 68. Key Industry Trends of Felodipine Sustained-Release Tablet
Table 69. Felodipine Sustained-Release Tablet Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Felodipine Sustained-Release Tablet Distributors List
Table 72. Felodipine Sustained-Release Tablet Customer List
Table 73. Global Felodipine Sustained-Release Tablet Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Felodipine Sustained-Release Tablet Sales Market Forecast by Region
Table 75. Global Felodipine Sustained-Release Tablet Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Felodipine Sustained-Release Tablet Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Felodipine Sustained-Release Tablet Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Felodipine Sustained-Release Tablet Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Felodipine Sustained-Release Tablet Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Felodipine Sustained-Release Tablet Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Felodipine Sustained-Release Tablet Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Felodipine Sustained-Release Tablet Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Felodipine Sustained-Release Tablet Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Felodipine Sustained-Release Tablet Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Felodipine Sustained-Release Tablet Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Felodipine Sustained-Release Tablet Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Felodipine Sustained-Release Tablet Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Felodipine Sustained-Release Tablet Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Felodipine Sustained-Release Tablet Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Felodipine Sustained-Release Tablet Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Felodipine Sustained-Release Tablet Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Felodipine Sustained-Release Tablet Revenue Market Share Forecast by Application (2023-2028)
Table 93. Astrazeneca Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 94. Astrazeneca Felodipine Sustained-Release Tablet Product Offered
Table 95. Astrazeneca Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Astrazeneca Main Business
Table 97. Astrazeneca Latest Developments
Table 98. NanJing Easeheal Phaemaecutical Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 99. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product Offered
Table 100. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. NanJing Easeheal Phaemaecutical Main Business
Table 102. NanJing Easeheal Phaemaecutical Latest Developments
Table 103. SHANXI KANGBO BIOLOGICAL PRODUCT Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 104. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product Offered
Table 105. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. SHANXI KANGBO BIOLOGICAL PRODUCT Main Business
Table 107. SHANXI KANGBO BIOLOGICAL PRODUCT Latest Developments
Table 108. Lifeon Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 109. Lifeon Felodipine Sustained-Release Tablet Product Offered
Table 110. Lifeon Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Lifeon Main Business
Table 112. Lifeon Latest Developments
Table 113. Changzhou Siyao Pharmaceutical Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 114. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product Offered
Table 115. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Changzhou Siyao Pharmaceutical Main Business
Table 117. Changzhou Siyao Pharmaceutical Latest Developments
Table 118. Mylan Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 119. Mylan Felodipine Sustained-Release Tablet Product Offered
Table 120. Mylan Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Mylan Main Business
Table 122. Mylan Latest Developments
Table 123. Sandoz Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 124. Sandoz Felodipine Sustained-Release Tablet Product Offered
Table 125. Sandoz Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Sandoz Main Business
Table 127. Sandoz Latest Developments
List of Figures
Figure 1. Picture of Felodipine Sustained-Release Tablet
Figure 2. Felodipine Sustained-Release Tablet Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Felodipine Sustained-Release Tablet Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Felodipine Sustained-Release Tablet Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Felodipine Sustained-Release Tablet Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 2.5mg Per Tablet
Figure 10. Product Picture of 5mg Per Tablet
Figure 11. Product Picture of Others
Figure 12. Global Felodipine Sustained-Release Tablet Sales Market Share by Type in 2021
Figure 13. Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2017-2022)
Figure 14. Felodipine Sustained-Release Tablet Consumed in Treat High Blood Pressure
Figure 15. Global Felodipine Sustained-Release Tablet Market: Treat High Blood Pressure (2017-2022) & (K Units)
Figure 16. Felodipine Sustained-Release Tablet Consumed in Relieve Angina
Figure 17. Global Felodipine Sustained-Release Tablet Market: Relieve Angina (2017-2022) & (K Units)
Figure 18. Felodipine Sustained-Release Tablet Consumed in Others
Figure 19. Global Felodipine Sustained-Release Tablet Market: Others (2017-2022) & (K Units)
Figure 20. Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2022)
Figure 21. Global Felodipine Sustained-Release Tablet Revenue Market Share by Application in 2021
Figure 22. Felodipine Sustained-Release Tablet Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Felodipine Sustained-Release Tablet Revenue Market Share by Company in 2021
Figure 24. Global Felodipine Sustained-Release Tablet Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Felodipine Sustained-Release Tablet Revenue Market Share by Geographic Region in 2021
Figure 26. Global Felodipine Sustained-Release Tablet Sales Market Share by Region (2017-2022)
Figure 27. Global Felodipine Sustained-Release Tablet Revenue Market Share by Country/Region in 2021
Figure 28. Americas Felodipine Sustained-Release Tablet Sales 2017-2022 (K Units)
Figure 29. Americas Felodipine Sustained-Release Tablet Revenue 2017-2022 ($ Millions)
Figure 30. APAC Felodipine Sustained-Release Tablet Sales 2017-2022 (K Units)
Figure 31. APAC Felodipine Sustained-Release Tablet Revenue 2017-2022 ($ Millions)
Figure 32. Europe Felodipine Sustained-Release Tablet Sales 2017-2022 (K Units)
Figure 33. Europe Felodipine Sustained-Release Tablet Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Felodipine Sustained-Release Tablet Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Felodipine Sustained-Release Tablet Revenue 2017-2022 ($ Millions)
Figure 36. Americas Felodipine Sustained-Release Tablet Sales Market Share by Country in 2021
Figure 37. Americas Felodipine Sustained-Release Tablet Revenue Market Share by Country in 2021
Figure 38. United States Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Felodipine Sustained-Release Tablet Sales Market Share by Region in 2021
Figure 43. APAC Felodipine Sustained-Release Tablet Revenue Market Share by Regions in 2021
Figure 44. China Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Felodipine Sustained-Release Tablet Sales Market Share by Country in 2021
Figure 51. Europe Felodipine Sustained-Release Tablet Revenue Market Share by Country in 2021
Figure 52. Germany Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Felodipine Sustained-Release Tablet Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Felodipine Sustained-Release Tablet Revenue Market Share by Country in 2021
Figure 59. Egypt Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Felodipine Sustained-Release Tablet in 2021
Figure 65. Manufacturing Process Analysis of Felodipine Sustained-Release Tablet
Figure 66. Industry Chain Structure of Felodipine Sustained-Release Tablet
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...